OTC Products - France

France

Highlights

In France, the projected revenue in the OTC Products market is estimated to reach US$4.70bn by 2024.
It is expected to exhibit an annual growth rate of 1.94% (CAGR 2024-2029), resulting in a market volume of US$5.17bn by 2029.
When compared globally, China is anticipated to generate the highest revenue in the OTC Products market, reaching US$74.91bn in 2024.
In terms of per person revenues, in France, each individual is expected to generate US$72.38 in 2024.
The OTC Products market serves as a significant market within the overall market scenario.
The demand for OTC products in France has been steadily increasing due to the country's strong healthcare system and emphasis on self-medication.

Key regions:

Market definitionIn-Scope/Out-of-scopeMarket structureReportsMethodology

The OTC Products (Pharmacies) market in France has been experiencing steady growth in recent years.

Customer preferences: French consumers have shown a growing preference for OTC products as a convenient and cost-effective alternative to prescription medications. This shift in consumer behavior can be attributed to several factors. Firstly, there is a growing awareness among consumers about the benefits and safety of OTC products, which has led to increased trust and confidence in these products. Additionally, the availability of a wide range of OTC products in pharmacies has made it easier for consumers to access the medications they need without having to visit a doctor.

Trends in the market: One of the key trends in the OTC Products (Pharmacies) market in France is the increasing demand for natural and herbal remedies. Consumers are becoming more conscious about their health and are seeking alternative treatments that are perceived to be more natural and less harmful. This trend is driven by a desire for holistic health and wellness, as well as a growing distrust of synthetic chemicals. As a result, pharmacies in France are expanding their range of natural and herbal OTC products to meet this growing demand. Another significant trend in the market is the rise of online pharmacies. With the increasing popularity of e-commerce, more and more consumers are turning to online platforms to purchase their OTC products. Online pharmacies offer convenience, competitive pricing, and a wide selection of products. This trend has been further accelerated by the COVID-19 pandemic, which has led to an increased reliance on online shopping for healthcare products. As a result, traditional brick-and-mortar pharmacies are adapting to this shift by expanding their online presence and offering home delivery services.

Local special circumstances: The French healthcare system plays a significant role in shaping the OTC Products (Pharmacies) market. The country has a universal healthcare system, which provides access to affordable healthcare for all citizens. This system includes a network of pharmacies that are heavily regulated and licensed by the government. These regulations ensure the quality and safety of OTC products sold in pharmacies, which in turn, instills trust and confidence among consumers.

Underlying macroeconomic factors: The OTC Products (Pharmacies) market in France is also influenced by underlying macroeconomic factors. The country has a stable economy with a high standard of living, which allows consumers to afford OTC products. Additionally, the aging population in France is driving the demand for OTC products, as older individuals often require medications for chronic conditions and general health maintenance. Furthermore, the government's focus on preventive healthcare and self-care has also contributed to the growth of the OTC Products (Pharmacies) market, as it encourages individuals to take responsibility for their own health and well-being. In conclusion, the OTC Products (Pharmacies) market in France is experiencing growth due to changing customer preferences, including a preference for natural and herbal remedies, as well as the rise of online pharmacies. The local special circumstances, such as the regulated healthcare system and the government's focus on preventive healthcare, also contribute to the market's development. Additionally, underlying macroeconomic factors, such as the stable economy and aging population, further drive the demand for OTC products in France.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.